CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Oppose medical device tariffs. Support data exclusivity provisions in USMCA / Oppose proposals to reduce data exclusivity.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MOLLY FISHMAN | — |
Taxation/Internal Revenue Code TAX
Support repeal of medical device tax. Support orphan drug tax credit and R & D tax credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MOLLY FISHMAN | — |
Medical/Disease Research/Clinical Labs MED
Support NIH research funding. Support implementation of 21st Century Cures Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MOLLY FISHMAN | — |
Copyright/Patent/Trademark CPT
Address concerns with provisions of patent litigation reform, including inter partes review. Support STRONGER Patents Act. Support Hatch Waxman Integrity Act. Oppose "march-in" rights and "compulsory licensing" proposals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MOLLY FISHMAN | — |
Health Issues HCR
Support FDA user fee programs and review process consistency and predictability. Support PAHPA reauthorization. Support policy improvements to address antimicrobial resistance.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MOLLY FISHMAN | — |
Medicare/Medicaid MMM
Address concerns with changes to Medicare Part B and Part D programs, and Hospital Outpatient Prospective Payment System. Address concerns with Medicare Advantage step therapy proposal and Medicare Part D protected classes proposal. Support Advancing Access to Precision Medicine Act. Oppose changes to Medicare Advantage and Part D prescription drug benefit. Support reforms to enable Value Based Healthcare. Oppose International Pricing Index/reference pricing in Medicare Part B. Support Ensuring Patient Access to/coverage of critical breakthrough products via Hospital Inpatient Prospective Payment System proposed rule and legislation. Oppose Medicare negotiating proposals that include compulsory licensing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MOLLY FISHMAN | — |
Budget/Appropriations BUD
Labor/HHS/Ed Appropriations: NIH, antimicrobial resistance, biodefense/pandemic, science/math education, and strategic stockpile funding and preparation; FDA Appropriations; PTO Appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MOLLY FISHMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.